Isoray, inc. (ISR)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10
Sales, net

2,880

2,206

2,315

1,924

1,924

1,904

1,562

-

1,573

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product sales, net

-

-

-

-

-

-

-

-

-

1,536

1,211

-

1,282

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of sales

1,174

1,095

1,079

1,045

1,045

1,139

1,038

1,166

964

1,005

946

-

989

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product sales, net

-

-

-

-

-

-

-

-

-

-

-

-

-

1,028

1,081

-

1,199

1,189

1,261

1,340

1,158

1,065

1,042

949

1,134

1,085

1,049

1,242

1,251

975

1,056

1,311

1,317

1,228

1,213

1,256

1,410

1,244

1,327

Cost of product sales

-

-

-

-

-

-

-

-

-

-

-

-

-

1,029

1,033

-

1,132

1,162

1,178

1,135

1,102

1,103

1,096

1,085

1,083

1,119

1,127

1,098

1,065

1,134

1,076

1,077

1,113

1,029

1,147

799

1,053

1,117

1,111

Gross profit

1,706

1,111

1,236

879

879

765

524

437

609

531

265

498

293

-1

48

-48

67

27

83

204

55

-37

-54

-136

50

-33

-77

143

185

-158

-20

233

204

198

66

456

357

127

215

Research and development:
Proprietary research and development

294

277

233

341

299

395

394

436

317

311

287

283

166

150

172

-

183

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration arrangement, net of reimbursement

-

-

-

0

0

19

26

135

156

29

75

33

161

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total research and development

294

277

233

341

299

414

420

571

473

340

362

316

327

150

172

143

183

58

144

156

141

140

176

198

153

170

146

181

155

149

141

207

132

189

251

606

244

15

114

Research and development reimbursement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

50

-

56

149

-

Sales and marketing

805

666

815

683

645

702

649

680

692

674

614

760

530

496

524

520

301

254

278

455

374

303

353

303

245

326

359

367

290

322

316

338

259

304

314

287

235

335

373

Gain on equipment disposal

-

-

-

-

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Gain) on equipment disposal

-

-

-

-

-

23

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative

1,155

1,071

1,097

999

1,099

1,101

973

1,556

783

985

841

1,288

825

880

927

999

910

1,125

752

697

589

537

575

682

640

513

651

615

564

469

644

629

575

497

652

637

627

561

596

Gain on change in estimate of asset retirement obligation

0

0

73

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in estimate of asset retirement obligation

-

-

-

-

-

-

-

-

-

-

-

-

0

48

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

2,254

2,014

2,072

2,023

2,042

2,194

2,042

2,807

1,948

1,999

1,817

2,362

1,682

1,478

1,623

1,206

1,394

1,437

1,174

1,309

1,106

982

1,106

1,184

1,039

1,010

1,157

1,164

1,010

940

1,102

1,174

967

990

1,168

1,222

1,050

762

1,084

Operating loss

-548

-903

-836

-1,144

-1,163

-1,429

-1,518

-2,370

-1,339

-1,468

-1,552

-1,864

-1,389

-1,479

-1,575

-1,254

-1,327

-1,410

-1,091

-1,104

-1,051

-1,020

-1,161

-1,320

-988

-1,044

-1,234

-1,020

-824

-1,099

-1,122

-940

-762

-792

-1,102

-766

-693

-634

-868

Non-operating income:
Interest income, net

3

6

20

49

34

15

10

11

7

5

6

30

29

29

30

52

54

56

56

68

68

72

72

10

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1

Change in fair value of warrant derivative liability

-

-

-

-

-

-

-

-

-

-

-

0

0

0

27

18

78

43

15

-0

28

41

306

-368

-1,095

117

-36

27

109

-55

129

-

213

166

-

-

-163

420

-

Other income

-

-

-

-

2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

0

0

20

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing and interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

0

0

3

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Financing and interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

55

3

2

0

23

174

14

4

Non-operating income

3

6

20

49

36

15

10

11

7

5

6

10

29

29

77

69

132

99

71

69

97

113

375

-357

-1,094

117

-36

27

109

-54

129

-264

209

163

0

54

-336

406

-3

Net loss

-545

-897

-816

-1,095

-1,127

-1,414

-1,508

-2,359

-1,332

-1,463

-1,546

-1,854

-1,360

-1,450

-1,498

-1,185

-1,195

-1,311

-1,020

-1,034

-953

-906

-785

-1,677

-2,083

-926

-1,270

-993

-715

-1,154

-993

-1,205

-552

-628

-1,102

-711

-1,030

-228

-871

Preferred stock deemed dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

726

0

0

0

0

-

-

-

-

-

-

-

-

Preferred stock dividends

3

2

3

3

3

2

3

2

3

3

3

3

3

2

3

2

3

3

3

3

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

Net loss applicable to common shareholders

-548

-899

-819

-1,098

-1,130

-1,416

-1,511

-2,361

-1,335

-1,466

-1,549

-1,857

-1,363

-1,452

-1,501

-1,187

-1,198

-1,314

-1,023

-1,037

-956

-909

-788

-1,680

-2,086

-929

-1,999

-996

-717

-1,156

-996

-1,207

-555

-631

-1,104

-714

-1,032

-230

-874

Basic and diluted loss per share (in dollars per share)

-0.01

-0.01

-0.01

-0.02

-0.02

-0.02

-0.02

-0.04

-0.02

-0.03

-0.03

-0.03

-0.02

-0.03

-0.03

-0.03

-0.02

-0.02

-0.02

-0.02

-0.02

-0.02

-0.01

-0.03

-0.05

-0.02

-0.06

-0.03

-0.02

-0.03

-0.03

-0.04

-0.02

-0.02

-0.04

-0.02

-0.04

-0.01

-0.04

Weighted average shares used in computing net loss per share:
Basic and diluted (in shares)

67,558

67,388

67,388

67,357

67,333

67,331

66,147

110,424

55,100

55,056

55

55,019

55,017

55,017

55,011

55,010

55,023

55,014

55,013

54,892

54,883

54,883

54,868

53,853

42,506

38,419

35,921

34,610

34,611

34,604

33,866

30,090

29,316

28,593

26,487

-

-

-

-

Basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

26,008

25,070

23,048